[4-(4-propylphenyl)phenyl]boronic acid | CAS:153035-56-4

We serve [4-(4-propylphenyl)phenyl]boronic acid CAS:153035-56-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
[4-(4-propylphenyl)phenyl]boronic acid

Product Name: [4-(4-propylphenyl)phenyl]boronic acid
Other Name:
[4-(4-propylphenyl)phenyl]boronic acid
(4'-Propyl-4-biphenylyl)boronic acid
4'-n-propyl-4-biphenylboronic acid
(4'-Propyl[1,1'-biphenyl]-4-yl)-boronic acid
CAS No: 153035-56-4
MF: C15H17BO2
MW: 240.10500
Density: 1.1±0.1 g/cm3
Boiling point: 413.1±48.0 °C at 760 mmHg
Melting point: N/A
Flash point: 203.6±29.6 °C
Refractive index: 1.581
UN Number: UN2811
Transport hazard class: 6.1
Packing group: III
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate, OLED intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like [4-(4-propylphenyl)phenyl]boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4′-Propyl[1,1′-biphenyl]-4-yl)-boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4′-Propyl[1,1′-biphenyl]-4-yl)-boronic acid Use and application,(4′-Propyl[1,1′-biphenyl]-4-yl)-boronic acid technical grade,usp/ep/jp grade.


Related News: The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen’s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.5-Chloro-2,3-dibromopyridine manufacturer The insulin-only and bihormonal configurations may be helpful in diabetes.9-bromo-10-(4-phenylnaphthyl-1-yl)anthracene supplier But several border points remain open, and many medical workers fear that Hong Kong’s well-regarded health care system will be overwhelmed.3,5-Dimethyl-4-hydroxybenzonitrile vendor The Philippines reported its first Wuhan coronavirus fatality on Sunday.Social media users — including numerous medical experts — questioned whether the findings were supported by clinical evidence from treating coronavirus patients.